The full list of publications can be found here:
https://pubmed.ncbi.nlm.nih.gov/?term=oricchio+e
2023
Chromatin organization in red triangles
E. Oricchio
Nature Reviews Genetics. 2023-02-02. DOI : 10.1038/s41576-023-00582-0. Whole genome doubling promotes tumorigenesis through loss of chromatin segregation and compartment repositioning
R-A. Lambuta / E. Oricchio (Dir.)
Lausanne, EPFL, 2023. 2022
New approaches to uncover the minimally functional hematopoietic niche using the adipocytic differentiation axis: pharmacological modulation and adrenal niche induction
F. Schyrr / E. Oricchio; O. M. Naveiras Torres-Quiroga (Dir.)
Lausanne, EPFL, 2022. 2021
Genomic studies indicate a novel combination therapy for follicular lymphoma COMMENT
E. Oricchio; H-G. Wendel
Molecular & Cellular Oncology. 2021-11-02. Vol. 8, num. 6, p. e969640. DOI : 10.4161/23723548.2014.969640. Systematic inference and comparison of multi-scale chromatin sub-compartments connects spatial organization to cell phenotypes
Y. Liu; L. Nanni; S. Sungalee; M. Zufferey; D. Tavernari et al.
Nature Communications. 2021-05-10. Vol. 12, num. 1, p. 2439. DOI : 10.1038/s41467-021-22666-3. 2020
The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity
F. Fico; A. Santamaria-Martinez
Cancers. 2020-12-01. Vol. 12, num. 12, p. 3863. DOI : 10.3390/cancers12123863. TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
F. Fico; A. Santamaria-Martinez
Molecular Oncology. 2020-11-05. Vol. 14, num. 12, p. 3198-3210. DOI : 10.1002/1878-0261.12828. A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice
P. Roidos; S. Sungalee; S. Benfatto; O. Sercin; A. M. Stuetz et al.
Nature Communications. 2020-08-14. Vol. 11, num. 1, p. 4077. DOI : 10.1038/s41467-020-17962-3. De novo protein design enables the precise induction of RSV-neutralizing antibodies
F. Sesterhenn; C. Yang; J. Bonet; J. T. Cramer; X. Wen et al.
Science. 2020-05-15. Vol. 368, num. 6492, p. eaay5051730. DOI : 10.1126/science.aay5051. Genome-wide Screens Implicate Loss of Cullin Ring Ligase 3 in Persistent Proliferation and Genome Instability in TP53-Deficient Cells
A. P. Drainas; R. A. Lambuta; I. Ivanova; O. Sercin; I. Sarropoulos et al.
Cell Reports. 2020-04-07. Vol. 31, num. 1, p. 107465. DOI : 10.1016/j.celrep.2020.03.029. 2019
Histone Modifications in Development and Malignancy
E. Oricchio
2019-11-13. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, Dec 07-10, 2019. DOI : 10.1182/blood-2019-121289. A Tale of Two Tumors: Unraveling the Complexities of Epigenetic Dysregulation in Cancer
M. C. Donaldson / E. Oricchio (Dir.)
Lausanne, EPFL, 2019. Novel therapeutic strategies targeting the B-cell receptor signaling and antigen presentation pathways in non-Hodgkin lymphoma
E. Battistello / E. Oricchio; G. Ciriello (Dir.)
Lausanne, EPFL, 2019. 2018
2017
2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
M. Boice; D. Salloum; F. Mourcin; V. Sanghvi; R. Amin et al.
Cell. 2016. Vol. 167, num. 2, p. 405-418.e13. DOI : 10.1016/j.cell.2016.08.032. 2014
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
E. Oricchio; G. Ciriello; M. Jiang; M. H. Boice; J. H. Schatz et al.
The Journal of experimental medicine. 2014. Vol. 211, num. 7, p. 1379-91. DOI : 10.1084/jem.20132120. 2013
Functional genomics lead to new therapies in follicular lymphoma
E. Oricchio; H-G. Wendel
Annals of the New York Academy of Sciences. 2013. Vol. 1293, p. 18-24. DOI : 10.1111/nyas.12120. 2011
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
J. H. Schatz; E. Oricchio; A. L. Wolfe; M. Jiang; I. Linkov et al.
The Journal of experimental medicine. 2011. Vol. 208, num. 9, p. 1799-807. DOI : 10.1084/jem.20110846.